🔎 Trials Near Me

Home › Neuroblastoma › Alabama › Birmingham

Pag-aaral pangklinika para sa Neuroblastoma sa Birmingham, AL

Isang pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Birmingham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3
  • Children's Hospital of Alabama, Birmingham
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Nagre-recruitPhase 2
  • University of Alabama/Children's of Alabama, Birmingham
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Nagre-recruitPhase 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Nagre-recruitPhase 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Nagre-recruitPhase 3
  • Children's Hospital of Alabama, Birmingham
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Nagre-recruitPhase 2
  • University of Alabama/Children's of Alabama, Birmingham
12 Months – 21 Years · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05489887

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Nagre-recruitPhase 2
  • Children's Hospital of Alabama/UAB, Birmingham
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.